| Name | Title | Contact Details |
|---|
Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Our portable point-of-care diagnostic platform, with built-in wireless connectivity and an intuitive cloud-based data management system, provides the real-time information necessary to improve clinical outcomes for individual patients and support global disease elimination programs. Daktari`s initial products will target viruses of worldwide significance, including Hepatitis C and HIV. The company recently announced a Hepatitis C partnership with Merck & Co (MSD).
Elara Caring is one of the nation`s largest providers of home-based care, with a national footprint in the Northeast, Midwest and Southwest. Elara brings together three award-winning organizations – Great Lakes Caring, National Home Health Care, and Jordan Health Services – into one transformational company, which provides the highest-quality comprehensive care continuum of personal care, skilled home health, and hospice care. The company is comprised of 32,500 caregivers serving over 65,000 patients and their families daily, in 225 locations across 16 states and focused on providing our patients with the “right care, at the right time, in the right place.”
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Kellogg Community Federal Credit Union is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Lancaster, PA. To find more information about Kellogg Community Federal Credit Union, please visit www.kelloggcfcu.org
Oakwood Place Assisted Living is a Davenport, IA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.